Literature DB >> 9494517

Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse.

G Soos1, R F Jones, G P Haas, C Y Wang.   

Abstract

BACKGROUND: More than 75% of patients with advanced prostate carcinoma have skeletal involvement, which is the principal metastatic site and the major complication of this disease. The goal of this work was to compare the osseous metastasis of androgen-sensitive and insensitive prostate cancers in the nude mouse.
MATERIALS AND METHODS: Androgen-sensitive LNCaP or -insensitive PC-3 human prostate carcinoma cells were injected directly into the femur medullas of male nude Beige mice, the animals were then sacrificed at successive time intervals to study the gross and microscopic characteristics of the established tumors.
RESULTS: LNCaP and PC-3 both colonized in the bone marrow within a week, then gradually expanded to the entire bone medulla followed by osseous infiltration to produce obvious symptoms in the affected extremities. Based on the morphology, both osteoblastic and osteolytic changes occurred during the course of tumor progression. In addition, PC-3 tumors eventually broke through the bone cortex, invaded the surrounding tissues, and metastasized to the regional lymph nodes. In contrast, LNCaP remained localized within the bone, and appeared to eventually regress and die after displacing the normal bone marrow cells. Immunohistochemically, LNCaP tumors were consistently positive for prostate-specific antigen in bone metastasis, while PC-3 tumors were negative. Tumor cell nuclei of both PC-3 and LNCaP hybridized to a human repeated sequence DNA probe indicating that the proliferating malignant cells were of human origin.
CONCLUSIONS: These cancer cell lines produced a high incidence of growth in the bone that differed in histogenesis. The relative malignancy of these cell lines was demonstrated in this model.

Entities:  

Mesh:

Year:  1997        PMID: 9494517

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Non-invasive microCT imaging characterization and in vivo targeting of BB2 receptor expression of a PC-3 bone metastasis model.

Authors:  Christopher T Winkelmann; Said Daibes Figueroa; Gary L Sieckman; Tammy L Rold; Timothy J Hoffman
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

2.  Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Authors:  J Zhang; J Dai; Y Qi; D L Lin; P Smith; C Strayhorn; A Mizokami; Z Fu; J Westman; E T Keller
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 3.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

4.  Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation.

Authors:  Ronald R Gomes; Patricia Buttke; Emmanuel M Paul; Robert A Sikes
Journal:  Clin Exp Metastasis       Date:  2009-05-07       Impact factor: 5.150

5.  Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.

Authors:  Britta Vormoor; Henrike K Knizia; Michael A Batey; Gilberto S Almeida; Ian Wilson; Petra Dildey; Abhishek Sharma; Helen Blair; I Geoff Hide; Olaf Heidenreich; Josef Vormoor; Ross J Maxwell; Chris M Bacon
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.